Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magnus Korsgren

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
American Journal of Respiratory Cell and Molecular Biology|March 29, 2003
Acute allergic responses induce a prompt luminal entry of airway tissue eosinophilsJonas S Erjefalt, Magnus Korsgren, Monika Malm-Erjefalt, et al.
Plos One|February 4, 2017
A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myelomaStina Wichert, Gunnar Juliusson, Åsa Johansson, et al.
Respiratory Research|March 3, 2007
Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammationLena Uller, Jesper Mosolff Mathiesen, Lisa Alenmyr, et al.
American Journal of Respiratory and Critical Care Medicine|March 11, 2003
Neural expression and increased lavage fluid levels of secretoneurin in seasonal allergic rhinitisMagnus Korsgren, Jonas S Erjefält, Josef Hinterholzl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2015
A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple MyelomaMarkus Hansson, Peter Gimsing, Ashraf Badros, et al.
JACC. Cardiovascular Imaging|January 12, 2015
Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humansHamed Emami, Parmanand Singh, Megan MacNabb, et al.
JACC. Cardiovascular Imaging|December 3, 2014
FDG-PET imaging for oxidized LDL in stable atherosclerotic disease: a phase II study of safety, tolerability, and anti-inflammatory activityJoshua Lehrer-Graiwer, Parmanand Singh, Amr Abdelbaky, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
American Journal of Respiratory Cell and Molecular Biology|March 29, 2003
Acute allergic responses induce a prompt luminal entry of airway tissue eosinophilsJonas S Erjefalt, Magnus Korsgren, Monika Malm-Erjefalt, et al.
Plos One|February 4, 2017
A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myelomaStina Wichert, Gunnar Juliusson, Åsa Johansson, et al.
Respiratory Research|March 3, 2007
Antagonism of the prostaglandin D2 receptor CRTH2 attenuates asthma pathology in mouse eosinophilic airway inflammationLena Uller, Jesper Mosolff Mathiesen, Lisa Alenmyr, et al.
American Journal of Respiratory and Critical Care Medicine|March 11, 2003
Neural expression and increased lavage fluid levels of secretoneurin in seasonal allergic rhinitisMagnus Korsgren, Jonas S Erjefält, Josef Hinterholzl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2015
A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple MyelomaMarkus Hansson, Peter Gimsing, Ashraf Badros, et al.
JACC. Cardiovascular Imaging|January 12, 2015
Splenic metabolic activity predicts risk of future cardiovascular events: demonstration of a cardiosplenic axis in humansHamed Emami, Parmanand Singh, Megan MacNabb, et al.
JACC. Cardiovascular Imaging|December 3, 2014
FDG-PET imaging for oxidized LDL in stable atherosclerotic disease: a phase II study of safety, tolerability, and anti-inflammatory activityJoshua Lehrer-Graiwer, Parmanand Singh, Amr Abdelbaky, et al.
Pageof 2